• 01:45

    In Short Order -- Linda Elesgood, LDN Research Trust

    in Health

    November 2-8 is LDN Awareness Week.  The 2014 LDN AIIC Conference is raising awareness about a ground-breaking drug (LDN) that has proven beneficial in treating over 175 health conditions


    Physicians, patients and experts from all over the world will gather in Las Vegas this November at a major conference to discuss and raise awareness about a ground-breaking drug that can help eradicate pain for those affected by a range of autoimmune diseases and conditions.


    The LDN 2014 AIIC Conference 2014 will take place on the 7th and 8th November at the MEET in Las Vegas with a number of high profile medical experts confirmed to speak. The conference also coincides with LDN Awareness Week 2014 which runs from 2nd-8th November 2014.


    Doctors around the world are now starting to realise the benefits of using LDN (Low Dose Naltrexone) to treat a range of conditions from Crohn’s and HIV to MS, ME, Lyme, arthritis, infertility and more.


     LDN has traditionally been used in higher doses (50mg) to treat drug/alcohol addicts but, since the 1980s, doctors have prescribed it in lower doses (3-4.5mg), and it is currently helping over a quarter of a million people worldwide suffering from a range of autoimmune conditions.


     As a result, and to raise awareness of how other people could be helped, the LDN Research Trust was set up in 2004. Since that time, the group’s popularity has grown rapidly with supporters from all over the world, including prominent physicians. 


     LDN works as an opiate antagonist, inhibiting natural endorphins thus forcing the body to produce more which, in turn, reduces painful symptoms and improves well-being and those using it have experienced a huge improvement in their conditions, with some disappearing altogether.


     The LDN 2014 AIIC Conference 2014 will include expert presenters and­ panelists, all streamed live.

  • 01:18

    All About LDN for Parkinson's Disease

    in Health

    Parkinsons Recovery is dedicated to identify any and all options that provide people relief from the symptoms of Parkinson's Disease. Reports indicate Low Dose Naltrexone (LDN) is one option that serves this purpose quite well indeed. The program today features Lexie Lindstrom and Julia Schopick, best-selling author of the book, "Honest Medicine" who answer questions about LDN. 


    Hear all about people who are having wonderful successes taking LDN and also from those who have been presented with challenges related to LDN, especially with reference to convincing their doctors to prescribe it for them. This program is by far, the most informative and inspirational show to date on the benefits of LDN for Parkinson's disease! 


    Robert Rodgers
    Host
    Parkinsons Recovery

     


     

  • 00:41

    In Short Order -- Robert Jones, Live Stream CEO for LDN Conference

    in Health

    The LDN Research Trust will be hosting the 2014 LDN AIIC Conference, November 7-8, Las Vegas. If you are not able to attend in person, Robert Jones has an inexpensive, interactive way for you to ask questions, view the presentations, and receive CMEs for your time.


    Please join Robert Jones and Linda Elesgood as thhey discuss the conference and all that it will have to offer.

  • 01:07

    Low Dose Naltrexone (LDN) ....Take 2!!!

    in Health

    Looking over the last several shows, the base theme is chronic inflammation....Sooo, this week I decided to replay My interview with Linda Elsegood concerning LDN or Low Dose Naltrexone that being sucessfully utilized to treat numerous chronic illnesses. Linda Elsegood is a leader in the movement to educate patients and doctors about LDN. Her tireless effort is bringing healing to many.


    Linda Elsegood was diagnosed with MS in 2000 at the age of 44. She started LDN 3rd Deb 2003 and founded the LDN Research Trust in Feb 2004 to tell other people find out about LDN and to find prescribing doctors and to help and support clinical trials of LDN. She has organised several LDN conferences, the next being in Las Vegas in Nov 2014.


    Her ultimate goal is for everyone with an autoimmune disease to be given LDN as a first line treatment and in the UK to have it on the NHS. LDN isn't a cure and doesn't work for everyone but it is something well worth researching!


    This information is worth re-visiting....tell your friends!!!

  • 00:58

    LDN and Chronic Illness...Does it Help?

    in Health

    LDN or Low Dose Naltrexone is being sucessfully utilized to treat numerous chronic illnesses. This week we have the honor of speaking with Linda Elsegood. She is a leader in the movement to educate patients and doctors about LDN. Her tireless effort is bringing healing to many.


    Linda Elsegood was diagnosed with MS in 2000 at the age of 44. She started LDN 3rd Deb 2003 and founded the LDN Research Trust in Feb 2004 to tell other people find out about LDN and to find prescribing doctors and to help and support clinical trials of LDN. She has organised several LDN conferences, the last being Oct 2013 in Chicago and the next being in Las Vegas this year.


    She is working with developers of an LDN Health Tracking app. And with  a documentary making and filing starts on 11th March and will finish at the LDN conference in November.


    Her ultimate goal is for everyone with an autoimmune disease to be given LDN as a first line treatment and in the UK to have it on the NHS. LDN isn't a cure and doesn't work for everyone but it is something well worth researching!


     

  • 00:53
  • 01:26

    2014 Recap..What Have We Learned? Q&A with Dr. Jess & Friends

    in Health

    Monday, December 22, 2014 at 8PM eastern, Dr. Jess Armine and friends will recap the year. What have we learned? Where do we need to go? What stones have been left unturned?


    We will have a short power point presentation overview of all the subjects we covered.....Then we want to hear from you....Did we do a good job? Have you been empowered with knowledge? What have we left out?


    There will be ample Q&A time....Join us and help carry us into the future!!!


    See you then!


     

  • 00:29

    In Short Order -- Dr. Michael Arata

    in Health

    A graduate of UCSF School of Medicine, Dr. Arata completed his residency at Duke University Medical Center and fellowship at the Hospital of the University of Pennsylvania. Dr. Arata is double board certified and internationally recognized for his work in venous medicine and autonomic dysfunction. Recently the focus of his practice has been Functional Medicine. Dr. Arata has several years of experience using LDN in his practice.

  • 00:20

    In Short Order -- Robert Jones, Live Streaming CEO

    in Health

    November 2-8 is LDN Awareness Week.  The 2014 LDN AIIC Conference is raising awareness about a ground-breaking drug (LDN) that has proven beneficial in treating over 175 health conditions


    Physicians, patients and experts from all over the world will gather in Las Vegas this November at a major conference to discuss and raise awareness about a ground-breaking drug that can help eradicate pain for those affected by a range of autoimmune diseases and conditions.


    The LDN 2014 AIIC Conference 2014 will take place on the 7th and 8th November at the MEET in Las Vegas with a number of high profile medical experts confirmed to speak.


    Doctors around the world are now starting to realize the benefits of using LDN (Low Dose Naltrexone) to treat a range of conditions from Crohn’s and HIV to MS, ME, Lyme, arthritis, infertility and more.


     LDN has traditionally been used in higher doses (50mg) to treat drug/alcohol addicts but, since the 1980s, doctors have prescribed it in lower doses (3-4.5mg), and it is currently helping over a quarter of a million people worldwide suffering from a range of autoimmune conditions.


     As a result, and to raise awareness of how other people could be helped, the LDN Research Trust was set up in 2004.


     LDN works as an opiate antagonist, inhibiting natural endorphins thus forcing the body to produce more which, in turn, reduces painful symptoms and improves well-being and those using it have experienced a huge improvement in their conditions, with some disappearing altogether.


     The LDN 2014 AIIC Conference 2014 will include expert presenters and­ panelists, all streamed live.


     
     http://www.ldnresearchtrust.org/ 




    Issued on behalf of LDN Research


    Contact: Linda Elesgood – contact@ldnresearchtrust.org

  • 02:03

    LDN Low-Dose Naltrexone

    in Health

    Interview with Dr. Sullivan about the use of LDN,  low-dose naltrexone, for the treatment of Multiple Sclerosis and other  Chronic Illnesses like Lupus .
     
    LISTEN on MSstation.com [AWARENESS]
       

  • 00:33

    In Short Order -- Dr. Mark Shukhman

    in Health

    Mark Shukhman MD is a psychiatrist in private practice in suburbs of Chicago. Prior to becoming an MD, his interests included alternative medicine and mathematics. Dr.Shukhman’s practice is focused on such problems as mood, anxiety, sleep, sex, appetite control, memory problems, chronic pain and addiction to opioids and alcohol. Dr.Shukhman is frequently consulted on psycho-somatic problems and psychiatric symptoms, accompanying general medical conditions. Treatment approach is based on neuropsychiatric interpretation of symptomatology and usually consists of combination of medications with vitamins, supplements and reflexotherapy. LDN is a part of psychopharmacological armamentarium for treatment of mood disorders, eating disorders and addictions.
    Dr. Shukman teaches, including “doctor teaching other doctors” He was on the faculty of a board preparation course, advisory panels, multiple grand rounds etc. He served as a primary investigator for a several pharmaceutical research studies.

Results Per Page: 12 | 24 | 48
Loading...
Loading...